HighVista Strategies’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,551
| Closed | -$427K | – | 141 |
|
|
2024
Q3 | $427K | Sell |
1,551
-1,051
| -40% | -$289K | 0.15% | 136 |
|
|
2024
Q2 | $632K | Buy |
+2,602
| New | +$632K | 0.23% | 112 |
|
|
2023
Q3 | – | Sell |
-4,056
| Closed | -$770K | – | 134 |
|
|
2023
Q2 | $770K | Hold |
4,056
| – | – | 0.35% | 72 |
|
|
2023
Q1 | $812K | Hold |
4,056
| – | – | 0.66% | 47 |
|
|
2022
Q4 | $964K | Sell |
4,056
-183
| -4% | -$43.5K | 0.57% | 46 |
|
|
2022
Q3 | $848K | Sell |
4,239
-749
| -15% | -$150K | 0.48% | 50 |
|
|
2022
Q2 | $728K | Sell |
4,988
-567
| -10% | -$82.8K | 0.44% | 53 |
|
|
2022
Q1 | $907K | Sell |
5,555
-1,538
| -22% | -$251K | 0.58% | 42 |
|
|
2021
Q4 | $1.2M | Buy |
7,093
+935
| +15% | +$159K | 0.96% | 33 |
|
|
2021
Q3 | $1.16M | Buy |
+6,158
| New | +$1.16M | 0.77% | 40 |
|
|
2020
Q3 | – | Sell |
-2,805
| Closed | -$415K | – | 117 |
|
|
2020
Q2 | $415K | Buy |
+2,805
| New | +$415K | 0.34% | 55 |
|